News tagged with glucagon
Study: Most-used diabetes drug works in different way than previously thought
A team, led by senior author Morris J. Birnbaum, MD, PhD, the Willard and Rhoda Ware Professor of Medicine, with the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University ...
Diabetes
Jan 06, 2013 |
5 / 5 (3) |
0
|
Study finds molecular switch that controls liver glucose production, may offer target for type II diabetes therapy
In their extraordinary quest to decode human metabolism, researchers at the Salk Institute for Biological Studies have discovered a pair of molecules that regulates the liver's production of glucose -- the ...
Medical research
Apr 08, 2012 |
3 / 5 (2) |
0
|
DNA variant affects diabetes risk and treatment response
A DNA variant near a digestive enzyme does not only affect risk of developing diabetes but also affects the response to treatment, an international consortium of researchers including the University of Dundee has found.
Diabetes
May 17, 2013 |
not rated yet |
0
|
Research suggests popular diabetes drugs can cause abnormal pancreatic growth in humans
(Medical Xpress)—Individuals who had taken a type of drug commonly used to treat Type 2 diabetes showed abnormalities in the pancreas, including cell proliferation, that may be associated with an increased risk of neuroendocrine ...
Diabetes
Mar 27, 2013 |
not rated yet |
0
|
Risk of pancreatitis doubles for those taking new class of diabetes drugs
People who take the newest class of diabetes drugs to control blood sugar are twice as likely as those on other forms of sugar-control medication to be hospitalized with pancreatitis, Johns Hopkins researchers report.
Medications
Feb 25, 2013 |
5 / 5 (2) |
1
|
New findings on glucagon synthesis
Researchers at Karolinska Institutet in Sweden have shown that the cells that produce glucagon are stimulated by the hormone itself. A previous study by the same group demonstrated that this principle also applies to insulin. ...
Medical research
Dec 03, 2012 |
5 / 5 (2) |
0
|
Doubling down against diabetes: Turbo-charged gut hormones
A collaboration between scientists in Munich, Germany and Bloomington, USA may have overcome one of the major challenges drug makers have struggled with for years: Delivering powerful nuclear hormones to specific tissues, ...
Medical research
Nov 13, 2012 |
5 / 5 (2) |
0
|
New inflammation hormone link may pave way to study new drugs for Type 2 diabetes
A new link between obesity and type 2 diabetes found in mice could open the door to exploring new potential drug treatments for diabetes, University of Michigan Health System research has found.
Diabetes
May 15, 2012 |
1 / 5 (1) |
0
|
Targeting glucagon pathway may offer a new approach to treating diabetes
Maintaining the right level of sugar in the blood is the responsibility not only of insulin, which removes glucose, but also of a hormone called glucagon, which adds glucose.
Diabetes
Apr 12, 2012 |
not rated yet |
0
|
Gut hormone leads to weight loss in overweight or obese patients
Giving overweight or obese patients a gut hormone that suppresses appetite leads to clinically beneficial weight loss as well as reduced blood pressure and cholesterol levels, finds a study published in the British Medical ...
Overweight and Obesity
Jan 10, 2012 |
not rated yet |
1
|
Researchers discover protein that may represent new target for treating type 1 diabetes
Researchers at Wake Forest Baptist Medical Center's Institute for Regenerative Medicine and colleagues have discovered a new protein that may play a critical role in how the human body regulates blood sugar levels. Reporting ...
Medical research
Jan 04, 2012 |
5 / 5 (1) |
0
|
Study suggests possible link between two Type 2 diabetes drugs and pancreatic cancer
Two newer drugs used to treat Type 2 diabetes could be linked to a significantly increased risk of developing pancreatitis and pancreatic cancer, and one could also be linked to an increased risk of thyroid cancer, according ...
Medications
Sep 16, 2011 |
5 / 5 (3) |
0
|
Diabetic medication may protect patients from developing heart failure, study finds
A class of medications commonly prescribed to lower blood sugar in diabetic patients appears to protect them from developing heart failure, according to a study at Henry Ford Hospital in Detroit.
Cardiology
Mar 10, 2013 |
not rated yet |
0
High-fat diet impairs satiation signaling in obese-prone
(HealthDay)—Feeding obese-prone rats a high-fat diet leads to impaired satiation signaling through glucagon-like peptide-1 (GLP-1), a gastrointestinal hormone that suppresses food intake and helps regulate ...
Diabetes
Feb 27, 2013 |
not rated yet |
0
Study suggests glucagon-like peptide-1 receptor agonists related to adolescent weight loss
Preliminary evidence from a clinical trial suggests that treatment with glucagon-like peptide-1 (GLP-1) receptor agonists was associated with reduced body mass index and body weight in adolescents with severe obesity, according ...
Pediatrics
Feb 04, 2013 |
not rated yet |
0
Glucagon
Glucagon, a hormone secreted by the pancreas, raises blood glucose levels. Its effect is opposite that of insulin, which lowers blood glucose levels. The pancreas releases glucagon when blood sugar (glucose) levels fall too low. Glucagon causes the liver to convert stored glycogen into glucose, which is released into the bloodstream. High blood glucose levels stimulate the release of insulin. Insulin allows glucose to be taken up and used by insulin-dependent tissues. Thus, glucagon and insulin are part of a feedback system that keeps blood glucose levels at a stable level. Glucagon belongs to a family of several other related hormones.
For more information about Glucagon, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
